Industry concern focuses more on nanotechnology for its potential to toxify natural products
Jul. 5, 2011 5:24pm
A promising phytochemical is one thing. Proven effi cacy in the human body is an entirely different matter. “Some of the more popular botanicals have poor bioavailability,” says Bill Gurley, PhD, professor of pharmaceutical sciences at the University of Arkansas for Medical Sciences. “Researchers are thinking, ‘If we can improve bioavailability, we should be able to improve efficacy.’ I think that’s a logical step to take.” “Bioavailability is something we’ve been concentrating on at NOW Foods for some time,” says the company’s nutrition education manager and product formulator, Neil...
Sign in to view
the full article
This article is part of our paid subscription packages. You need to subscribe (and sign in) to gain access to this Subscriber Only Content.
Why Subscribe to Nutrition Business Journal?
- In-depth perspective on the $226 billion global nutrition industry
- Receive monthly issues and access up to 5 years of back issues
- Downloadable data files, presentations, and more
Register Here to complete step one of the Premium Content subscription process